ARGENX SE revenue breakdown overview

ARGENX SE revenue for the last year amounted to 1.15 B EUR, the most of which — 1.11 B EUR — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 383.79 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ARGENX SE 975.40 M EUR, and the year before that — 352.87 M EUR.